Enteropathic spondyloarthritis (ESpA) encompasses a group of rheumatic disorders that share overlapping pathophysiology with other immune system disorders, particular those of the gut. Therefore, a multidisciplinary approach is important to recognizing the varied manifestations of ESpA in patients with IBD in order to achieve a prompt and accurate diagnosis leading to comprehensive care.
In HLA-B27-positive children with elevated CRP levels, the probability of having sacroiliitis was 0.84, compared with 0.33 in HLA-B27-negative children.
Although surgery can present challenges in patients with ankylosing spondylitis, awareness of situations and conditions warranting special attention can ensure optimal patient outcomes. Review this case study to explore appropriate pre-, peri-, and postoperative approaches. A knowledge-based assessment is also provided.
Results from the GO-REVEAL trial indicate that golimumab treatment is associated with long-term improvement in psoriatic arthritis.
Among patients with chronic back pain for ≥3 months beginning at age <45 years, the presence of ≥1 of 3 SpA features is an effective way to identify patients with possible axSpA.
Researchers found that nonradiographic axial spondyloarthritis patients had significantly lower levels of inflammation and affected fewer men than AS. The data suggest that nr-axSpA patients cannot be categorized as having pre-radiographic AS.
Uveitis flares occurred at a lower rate in patients treated with certolizumab pegol vs placebo.
Researchers observed changes in sacroiliac joint inflammation after a 12-week treatment with adalimumab.
The ASAS criteria classify more spondyloarthritis patients than ESSG or Amor criteria.
Researchers assessed the effect of physician education on time to diagnosis and referral to specialty care in patients with spondyloarthritis.
